# GLATIRAMER ACETATE
> **ANDA206936** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2017-10-03
## Drug
- **FDA Application Number:** ANDA206936
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GLATIRAMER ACETATE
- **Generic name:** GLATIRAMER
- **Active ingredients:** GLATIRAMER ACETATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** MYLAN
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2017-10-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206936)
---
*MORVS · CC0 1.0*